(4R)-3-[(2R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2-methylpropan-2-yl)oxy]oxan-2-yl]-4-phenyl-1,3-oxazolidin-2-one

C19H27NO6 — CID 11303051

IUPAC(4R)-3-[(2R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2-methylpropan-2-yl)oxy]oxan-2-yl]-4-phenyl-1,3-oxazolidin-2-one
SMILESCC(C)(C)O[C@@H]1C[C@H](N2C(=O)OC[C@H]2c2ccccc2)O[C@H](CO)[C@H]1O
InChIInChI=1S/C19H27NO6/c1-19(2,3)26-14-9-16(25-15(10-21)17(14)22)20-13(11-24-18(20)23)12-7-5-4-6-8-12/h4-8,13-17,21-22H,9-11H2,1-3H3/t13-,14+,15+,16+,17-/m0/s1
InChIKeyWEWPPGAFDCWAOZ-UTSKFRMZSA-N
MW365.43 g/mol
LogP1.83
Rot. Bonds4

About (4R)-3-[(2R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2-methylpropan-2-yl)oxy]oxan-2-yl]-4-phenyl-1,3-oxazolidin-2-one

(4R)-3-[(2R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2-methylpropan-2-yl)oxy]oxan-2-yl]-4-phenyl-1,3-oxazolidin-2-one (PubChem CID 11303051) has the molecular formula C19H27NO6 and a molecular weight of 365.43 g/mol. Its IUPAC name is (4R)-3-[(2R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2-methylpropan-2-yl)oxy]oxan-2-yl]-4-phenyl-1,3-oxazolidin-2-one.

Molecular Properties

Compound Name(4R)-3-[(2R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2-methylpropan-2-yl)oxy]oxan-2-yl]-4-phenyl-1,3-oxazolidin-2-one
PubChem CID11303051
Molecular FormulaC19H27NO6
Molecular Weight365.43 g/mol
Exact Mass365.18
IUPAC Name(4R)-3-[(2R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2-methylpropan-2-yl)oxy]oxan-2-yl]-4-phenyl-1,3-oxazolidin-2-one
SMILESCC(C)(C)O[C@@H]1C[C@H](N2C(=O)OC[C@H]2c2ccccc2)O[C@H](CO)[C@H]1O
InChIInChI=1S/C19H27NO6/c1-19(2,3)26-14-9-16(25-15(10-21)17(14)22)20-13(11-24-18(20)23)12-7-5-4-6-8-12/h4-8,13-17,21-22H,9-11H2,1-3H3/t13-,14+,15+,16+,17-/m0/s1
InChIKeyWEWPPGAFDCWAOZ-UTSKFRMZSA-N
XLogP1.83
TPSA88.46 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms26
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500365.43
LogP ≤ 51.83
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze (4R)-3-[(2R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2-methylpropan-2-yl)oxy]oxan-2-yl]-4-phenyl-1,3-oxazolidin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (4R)-3-[(2R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2-methylpropan-2-yl)oxy]oxan-2-yl]-4-phenyl-1,3-oxazolidin-2-one?
The IUPAC name of (4R)-3-[(2R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2-methylpropan-2-yl)oxy]oxan-2-yl]-4-phenyl-1,3-oxazolidin-2-one (CID 11303051) is (4R)-3-[(2R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2-methylpropan-2-yl)oxy]oxan-2-yl]-4-phenyl-1,3-oxazolidin-2-one.
What is the SMILES notation for (4R)-3-[(2R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2-methylpropan-2-yl)oxy]oxan-2-yl]-4-phenyl-1,3-oxazolidin-2-one?
The canonical SMILES for (4R)-3-[(2R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2-methylpropan-2-yl)oxy]oxan-2-yl]-4-phenyl-1,3-oxazolidin-2-one is CC(C)(C)O[C@@H]1C[C@H](N2C(=O)OC[C@H]2c2ccccc2)O[C@H](CO)[C@H]1O.
What is the InChIKey of (4R)-3-[(2R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2-methylpropan-2-yl)oxy]oxan-2-yl]-4-phenyl-1,3-oxazolidin-2-one?
The InChIKey is WEWPPGAFDCWAOZ-UTSKFRMZSA-N. The full InChI is InChI=1S/C19H27NO6/c1-19(2,3)26-14-9-16(25-15(10-21)17(14)22)20-13(11-24-18(20)23)12-7-5-4-6-8-12/h4-8,13-17,21-22H,9-11H2,1-3H3/t13-,14+,15+,16+,17-/m0/s1.
What are the key properties of (4R)-3-[(2R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2-methylpropan-2-yl)oxy]oxan-2-yl]-4-phenyl-1,3-oxazolidin-2-one?
(4R)-3-[(2R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2-methylpropan-2-yl)oxy]oxan-2-yl]-4-phenyl-1,3-oxazolidin-2-one has a molecular weight of 365.43 g/mol, XLogP of 1.83, 4 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (4R)-3-[(2R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2-methylpropan-2-yl)oxy]oxan-2-yl]-4-phenyl-1,3-oxazolidin-2-one is sourced from PubChem (CID 11303051), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).